猪心梗模型MRI心肌首过灌注及DE-MRI、cTnI实验研究
|
摘要
研究目的
心肌灌注减低发生于心电图(ECG)变化和临床出现心绞痛等综合征之前,因此心肌灌注异常对冠心病的诊断有积极的意义。
通过对猪心梗模型MRI心肌首过灌注成像(Fist-pass-perfusion MRI),探讨缺血心肌灌注曲线(时间-信号强度曲线)变化与局部心肌的存活情况,并对其目前应用中存在的局限性进行探讨。
方法:
制备成功10只心梗模型猪行术前及术后MRI心肌首过灌注检查,观察灌注图像有无灌注缺损或减低,并经图像后处理软件绘制灌注缺损区及周围、心肌下壁和侧壁时间信号强度曲线,对曲线峰值时间、峰值信号强度进行分析。MR工检查结束后处死实验猪,取出心脏,行心肌TTC组织化学检查和常规病理检查。
结果:
①符合实验研究10只猪术前未见心肌灌注减低或缺损。
②术后8只在前壁和(或)前间壁见心肌灌注减低和缺损,灌注缺损区曲线未见明显的波峰,在正常心肌灌注时间内为低灌注表现,后期曲线呈轻度上升表现;灌注缺损周围时间-信号强度曲线可见波峰,但峰值信号强度低于正常侧壁和下壁心肌(P<0.05),峰值时间较正常侧壁和下壁心肌延迟(P<0.05)。
③切片后行TTC染色和病理检查灌注缺损区均可见心肌梗死,灌注缺损周围心肌纤维见水肿、变性;无灌注缺损2只猪TTC染色和病理检查见小灶性心肌坏死区。
结论:
MRI心肌首过灌注检查可对心肌活性和缺血情况进行评估,灌注曲线可发现灌注图不能识别的缺血心肌;灌注曲线的不同走势和变化客观反映了局部心肌血流生理情况,心肌微循环灌注的改变以及生理病理的即时信息,但临床应用中还存在一定的局限性。
目的
MR延迟增强技术(Delayed-Enhancement MRI,DE-MRI)在对心肌活性的评价中,正快速成为一种突出有效的检查手段,相对于MRI心肌首过灌注,它具有更高的空间分辨率和CNR,并能扫描完整的心肌;但对DE-MRI高信号是否就是失活心肌还存在争议;同时临床更关注心梗节段的透壁程度对治疗的反应,而目前尚无心梗透壁程度与组织学的比较,多是测量心梗体积或面积;本研究通过对猪心梗模型DE-MRI和基础病理对照研究,旨在对上述问题进行探讨:研究其评价失活心肌的准确性、对心梗节段透壁程度判断的一致性,为DE-MRI临床运用提供更有力的实验依据。
方法
10只制备成功的猪急性心肌梗死模型分别于术前及术后24 h、72 h、1周分组行心脏DE-MR检查,观察DE-MRI图像上高信号部位、节段数与透壁程度;MRI检查完后,处死试验猪,取出心脏行TTC染色和病理检查,并对DE-MRI和TTC两者检测的梗死心肌节段、部位及透壁程度行统计学分析。
结果
①10只猪心梗模型制作成功,术前DE-MRI检查未见异常高信号节段。
②10只心梗模型猪术后DE-MRI均发现异常高信号心肌节段,共检测到30个高信号心肌节段,其检测的高信号心肌节段数及部位与TTC染色组所诊断心梗节段数及部位相比,差别统计学意义(McNemar Test,P>0.05)。
③对梗死心肌节段透壁程度的判断,DE-MRI和TTC染色两种方法诊断结果有关(Chi-Square test,P<0.05),且一致性较好(Kappa>0.75),但DE-MRI高信号节段透壁程度分级高于TTC染色组心梗透壁程度分级(McNemar Test,P<0.05)。
④DE-MRI高信号(TTC染色梗死区域)24小时病理表现为心肌细胞胞浆嗜酸性增强,呈均质样,核固缩。72小时病理表现为心肌纤维多灶性、不规则溶解消失,代之以大量增生的纤维母细胞。1周病理表现为心肌纤维溶解消失,间质纤维母细胞及毛细血管增生、炎细胞浸润,小血管扩张、充血。DE-MRI稍高信号区(TTC染色无梗死区域)见间质局灶水肿明显、部分心肌纤维显著水肿变性,胞浆淡然,气球样变。
结论
DE-MRI能准确检测失活心肌(梗死心肌),并能清楚描述失活心肌的透壁程度,其判断的心梗透壁程度与TTC染色相比一致性较好,这对于CAD的临床评价和治疗都非常重要;但应注意急性期DE-MRI显示高信号区会“放大”失活心肌,急性期心肌梗死DE-MRI高信号并非完全是失活心肌,少部分源于心肌纤维水样变性和间质局灶水肿导致的Gd造影剂分布容积增加,但部分高信号节段水肿区与梗死区亮度不一致,梗死区信号亮度更高。
目的
目前,在临床评价心肌活性手段中,DE-MRI正有望成为检测不可逆心肌新的金标准,而心脏肌钙蛋白(cTnT或cTnI)是目前临床上评价和判断患者心肌损伤最好的检测标志物,但临床上用于检测的心肌坏死标记物的试剂盒是针对人的血清,其是否适用于猪的血清?其检测的cTnI值与DE-MRI所判断的心梗损伤程度相关性如何?
本研究拟在对上述问题进行探讨,并与组织病理进行对照研究。
方法
10只制备成功的猪急性心肌梗死模型分别术前、术后1小时、术后2小时、术后5小时、24小时、48小时、72小时、1周采血,行心肌肌钙蛋白(cTnI)检测;并分组行术后24 h、72 h、1周心脏DE-MR检查,对DE-MRI所显示的心肌梗死程度进行评分;MRI检查完后,处死试验猪,取出心脏行TTC染色和免疫组化肌动蛋白(HHF35)、肌红蛋白(Mb)、结蛋白(Dm)检查。对cTnI峰值和DE-MRI、TTC染色所判断的心肌梗死程度评分Correlate(Bivariate)行相关分析。
结果
①心肌钙蛋白(cTnI)术后1小时可见上升,于24小时达高峰,此后逐渐下降,1周后回复至术前水平。
②10例免疫组织化均证实心肌梗死:24h组缺血坏死区显示HHF35、Myoglobin、Desmin三种蛋白显著减少,呈大片淡染,周围正常心肌细胞呈棕褐色阳性反应;72h组三种蛋白缺失较24h组明显,呈大片缺染表现,与周围正常染色阳性的棕褐色心肌分界清楚;1w组与72h组相比无明显变化。
③24小时TnI峰值与TTC和DE-MRI两者检测的心梗损伤程度评分高度相关,散点图可见有明显的直线相关关系,相关系数分别为0.85和0.84,P<0.05,有显著的统计学意义。
结论
临床上用于检测的人血清心肌坏死标记物的试剂盒对猪血清cTnI术前及术后检测,可反映心肌损伤;其24小时峰值与DE-MRI所判断的心肌损伤程度高度相关;DE-MRI是目前临床正开展的检测心肌活性一种非常有效、无创、并具有高空间分辨率、高信号对比(SNR)优势的一项检查技术,cTnI与DE-MRI的联合应用有助于结果的相互应证和互为补充,可更好准确地评价心肌梗死。
Objectives:
The reduce of myocardial perfusion occurs before the electrocardiogram(ECG) changes and clinical syndrome(angina),so myocardial perfusion abnormalities have a positive meaning in the diagnosis of coronary artery disease.The aim of this study is to explore the value of the first-pass myocardial perfusion MR imaging in evaluating the ischemic myocardial perfusion and viability.Especially,to investigate to perfusion curves(time-signal intensity curves) changes of the ischemic myocardium.In addition, to explore the limitations existing in the current MR first-pass perfusion imaging study.
Materials and Methods:
Ten porcine model with myocardial infarction had the preoperative and postoperative MR first-pass myocardial perfusion imaging examination.The perfusion reduce or defects on the MR myocardial perfusion imaging were observed. And the time-signal intensity curves in the regions with the perfusion reduce or defects and normal regions were drawed by the image post-processing software.The peak time,peak signal intensity of curve were statistical analyzed.After MRI examination,the experimental pigs were executed and its heart been had the TTC staining and pathological examination.
Results:
The preoperative myocardial perfusion in the all of the 10 pigs is nomal,but there is myocardial perfusion decrease and defect in 8 experimental pigs after operation.The curves in the area with perfusion defects have no obvious peak and have a sligtly increase in late time.The curves in the area around perfusion defect can be seen the peak,but the peak signal intensity is lower than normal inferior and lateral myocardial wall(P<0.05);and the peak time is delayed compared with normal inferior and lateral myocardial wall(P<0.05).There are myocardial infarction in the perfusion defects areas and its were certified by TTC staining and pathological examination.The interstitial edema and myocardial degeneration can be seen in the perfusion reduced areas.
Conclusion:
MRI fist-pass myocardial perfusion imaging combined with time-signal intensity curves analysis can evaluate perfusion changes of the regional myocardial microcirculation.It may be useful in assessing the ischemic myocardial viability.But there are some limitations in the the clinical application.
Objectives:
Delayed-enhancement MR imaging(DE-MRI) is rapidly becoming a prominent and effective means in the evaluation of myocardial viability,but there is a question about it,that is "bringt is dead"? This study aimed to explore the accuracy and question in assessment of myocardial viability by delayed-enhanced MR imaging.
Materials and Methods
A total of 15 pigs were used to make the acute myocardial infarction(MI) models,and then ten successful models were underwent delayed-enhancement MR imaging at preoperation,]postoperative 24 h,72 h and 1 W,respectively.The hyperenhanced regions and segments as well as their transmural extent on DE-MRI were observed. After MR examination,2,3,5-triphenyltetrazolium chlorid(TTC) staining and pathological examination were performed.The segments with MI detected by the DE-MRI and TTC staning were made statistical analysis.
Results
①Ten MI models were made,and no abnormal signals were found on pre-operative DE-MRI.
②The abnormal high signal myocardial segments were found in the all of 10 pigs after operation on delayed-enhancement MR imaging.There were a total of 30 hyperenhanced segments in ten MI models.And there was no difference in regions and segments with MI between DE-MRI and TTC staining.
③In the judging transmural extent of MI,the results of DE-MRI was correlative with TTC staining(Pearson Chi-Square,P<0.05);and the concordance was good(K>0.75).But the results of two methods was different(McNemar Test,P<0.05). The transmural extent judged by DE-MRI was higher than TTC staining.
④24-hour pathology of high signal area in DE-MRI(myocardial infarction in TTC staining) showed eosinophilic cytoplasm of myocardial cells,homogeneous degeneration,nuclear pyknosis;72-hour pathology showed multifocal myocardial fibers dissoloved irregularly.1-week pathology showed myocardial fibers dissoloved, interstitial fibroblasts and capillary proliferation,small blood vessels congestive.The pathology of slightly higher signal area in DE-MRI(non-infarcion in TTC staining) showed obvious interstitial edema,edema degeneration and balloon-like change of myocardial fibers.
Conclusion:
DE-MRI is an excellent tool for detecting the myocardial infarction.Especially,it can cleary demonstrate the suberdocardial or transmural myocardial infarction.That is very important for the clinical evaluation and treatment of the ischemic heart disease But in the clinical evaluation we should be noted that the bright areas on DE-MRI will may be "zoom" the real areas of myocardial infarction.And we should observe whether are brightness difference in high-intensity zone.
Objectives:
Cardiac troponin(cTnT or cTnI) is regarded as a best marker to determine the acute myocardial injury,In addition,the delayed enhancement MR imaging is becoming the new gold standard in the clinical myocardial viability assessment.This study to explore whether the clinic reagent for detection of the serum cardiac troponin I(cTnI) in the human can be applicable to swine model with acute myocardial infarction;And to investigate the relationships between the cTnl peak value and the degree of myocardial infarction quantificated by delayed-enhancment MR imaging(DE-MRI) and pathological findings.
Materials and Methods
10 successful pig model with acute myocardial infarction were underwent cardiac troponin(cTnI) detection at preoperation,]postoperative 1 h,2 h,after 5 h, 24 h,48 h,72 hours and 1 week;and also were underwent Delayed-Enhancement MR imaging at preoperation,postoperative 24 h,72 h and 1 W,respectively.After MR examination,2,3,5-triphenyltetrazolium chlorid(TTC) staining and immunohistochemistry examination were performed.The degree of myocardial infarction was assessed by DE-MRI and TTC.The cTnI value of 24h after the operation and the degree of myocardial infarction were made correlation analysis.
Results
①The cardiac troponin can be seen raise at 1h after operation,and reached the peak at 24h arfter aperation,then decrease gradually.1 week later the cTnI value return to preoperative levels.
②The segments of myocardial infarction were found in the all of 10 pigs on the immunohistochemistry examination.It displayed:24h group showed HHF35, Myoglobin,Desmin proteins significantly reduced in the infaction region,and pale staining,surrounded by normal myocardial cells with brown staining;72h group showed HHF35,Myoglobin,Desmin protein reduced than 24h group significantly, showed a large region with dyeing missing in the infarction region,and had the clear boundaries with the normal stained brown myocardium,1w group had no significant change compared with 72h group.
③The cTnI peak values of 24h was correlated strongly to the degree of myocardial infarction assessed by TTC(correlation coefficient=0.85,P=0.002) as well as to DE-MRI(correlation coefficient =0.84,P=0.002).The scatter plot shows a clear linear correlation between the cTnI peak values and the degree of myocardial infarction assessed by TTC and DE-MRI.
Conclusion:
The clinical reagent for detection of the serum cardiac troponin I(cTnI) can be applicable to swine model.The cTnI measurement,specially 24h after the operation, can reflects degree of myocardial injury.DE-MRI is currently a very effective, non-invasive technique,and has high spatial resolution in detection of myocardial viability.The cTnI combined with DE-MRI will be more help for clinical work and research in coronary heart disease.
心肌灌注减低发生于心电图(ECG)变化和临床出现心绞痛等综合征之前,因此心肌灌注异常对冠心病的诊断有积极的意义。
通过对猪心梗模型MRI心肌首过灌注成像(Fist-pass-perfusion MRI),探讨缺血心肌灌注曲线(时间-信号强度曲线)变化与局部心肌的存活情况,并对其目前应用中存在的局限性进行探讨。
方法:
制备成功10只心梗模型猪行术前及术后MRI心肌首过灌注检查,观察灌注图像有无灌注缺损或减低,并经图像后处理软件绘制灌注缺损区及周围、心肌下壁和侧壁时间信号强度曲线,对曲线峰值时间、峰值信号强度进行分析。MR工检查结束后处死实验猪,取出心脏,行心肌TTC组织化学检查和常规病理检查。
结果:
①符合实验研究10只猪术前未见心肌灌注减低或缺损。
②术后8只在前壁和(或)前间壁见心肌灌注减低和缺损,灌注缺损区曲线未见明显的波峰,在正常心肌灌注时间内为低灌注表现,后期曲线呈轻度上升表现;灌注缺损周围时间-信号强度曲线可见波峰,但峰值信号强度低于正常侧壁和下壁心肌(P<0.05),峰值时间较正常侧壁和下壁心肌延迟(P<0.05)。
③切片后行TTC染色和病理检查灌注缺损区均可见心肌梗死,灌注缺损周围心肌纤维见水肿、变性;无灌注缺损2只猪TTC染色和病理检查见小灶性心肌坏死区。
结论:
MRI心肌首过灌注检查可对心肌活性和缺血情况进行评估,灌注曲线可发现灌注图不能识别的缺血心肌;灌注曲线的不同走势和变化客观反映了局部心肌血流生理情况,心肌微循环灌注的改变以及生理病理的即时信息,但临床应用中还存在一定的局限性。
目的
MR延迟增强技术(Delayed-Enhancement MRI,DE-MRI)在对心肌活性的评价中,正快速成为一种突出有效的检查手段,相对于MRI心肌首过灌注,它具有更高的空间分辨率和CNR,并能扫描完整的心肌;但对DE-MRI高信号是否就是失活心肌还存在争议;同时临床更关注心梗节段的透壁程度对治疗的反应,而目前尚无心梗透壁程度与组织学的比较,多是测量心梗体积或面积;本研究通过对猪心梗模型DE-MRI和基础病理对照研究,旨在对上述问题进行探讨:研究其评价失活心肌的准确性、对心梗节段透壁程度判断的一致性,为DE-MRI临床运用提供更有力的实验依据。
方法
10只制备成功的猪急性心肌梗死模型分别于术前及术后24 h、72 h、1周分组行心脏DE-MR检查,观察DE-MRI图像上高信号部位、节段数与透壁程度;MRI检查完后,处死试验猪,取出心脏行TTC染色和病理检查,并对DE-MRI和TTC两者检测的梗死心肌节段、部位及透壁程度行统计学分析。
结果
①10只猪心梗模型制作成功,术前DE-MRI检查未见异常高信号节段。
②10只心梗模型猪术后DE-MRI均发现异常高信号心肌节段,共检测到30个高信号心肌节段,其检测的高信号心肌节段数及部位与TTC染色组所诊断心梗节段数及部位相比,差别统计学意义(McNemar Test,P>0.05)。
③对梗死心肌节段透壁程度的判断,DE-MRI和TTC染色两种方法诊断结果有关(Chi-Square test,P<0.05),且一致性较好(Kappa>0.75),但DE-MRI高信号节段透壁程度分级高于TTC染色组心梗透壁程度分级(McNemar Test,P<0.05)。
④DE-MRI高信号(TTC染色梗死区域)24小时病理表现为心肌细胞胞浆嗜酸性增强,呈均质样,核固缩。72小时病理表现为心肌纤维多灶性、不规则溶解消失,代之以大量增生的纤维母细胞。1周病理表现为心肌纤维溶解消失,间质纤维母细胞及毛细血管增生、炎细胞浸润,小血管扩张、充血。DE-MRI稍高信号区(TTC染色无梗死区域)见间质局灶水肿明显、部分心肌纤维显著水肿变性,胞浆淡然,气球样变。
结论
DE-MRI能准确检测失活心肌(梗死心肌),并能清楚描述失活心肌的透壁程度,其判断的心梗透壁程度与TTC染色相比一致性较好,这对于CAD的临床评价和治疗都非常重要;但应注意急性期DE-MRI显示高信号区会“放大”失活心肌,急性期心肌梗死DE-MRI高信号并非完全是失活心肌,少部分源于心肌纤维水样变性和间质局灶水肿导致的Gd造影剂分布容积增加,但部分高信号节段水肿区与梗死区亮度不一致,梗死区信号亮度更高。
目的
目前,在临床评价心肌活性手段中,DE-MRI正有望成为检测不可逆心肌新的金标准,而心脏肌钙蛋白(cTnT或cTnI)是目前临床上评价和判断患者心肌损伤最好的检测标志物,但临床上用于检测的心肌坏死标记物的试剂盒是针对人的血清,其是否适用于猪的血清?其检测的cTnI值与DE-MRI所判断的心梗损伤程度相关性如何?
本研究拟在对上述问题进行探讨,并与组织病理进行对照研究。
方法
10只制备成功的猪急性心肌梗死模型分别术前、术后1小时、术后2小时、术后5小时、24小时、48小时、72小时、1周采血,行心肌肌钙蛋白(cTnI)检测;并分组行术后24 h、72 h、1周心脏DE-MR检查,对DE-MRI所显示的心肌梗死程度进行评分;MRI检查完后,处死试验猪,取出心脏行TTC染色和免疫组化肌动蛋白(HHF35)、肌红蛋白(Mb)、结蛋白(Dm)检查。对cTnI峰值和DE-MRI、TTC染色所判断的心肌梗死程度评分Correlate(Bivariate)行相关分析。
结果
①心肌钙蛋白(cTnI)术后1小时可见上升,于24小时达高峰,此后逐渐下降,1周后回复至术前水平。
②10例免疫组织化均证实心肌梗死:24h组缺血坏死区显示HHF35、Myoglobin、Desmin三种蛋白显著减少,呈大片淡染,周围正常心肌细胞呈棕褐色阳性反应;72h组三种蛋白缺失较24h组明显,呈大片缺染表现,与周围正常染色阳性的棕褐色心肌分界清楚;1w组与72h组相比无明显变化。
③24小时TnI峰值与TTC和DE-MRI两者检测的心梗损伤程度评分高度相关,散点图可见有明显的直线相关关系,相关系数分别为0.85和0.84,P<0.05,有显著的统计学意义。
结论
临床上用于检测的人血清心肌坏死标记物的试剂盒对猪血清cTnI术前及术后检测,可反映心肌损伤;其24小时峰值与DE-MRI所判断的心肌损伤程度高度相关;DE-MRI是目前临床正开展的检测心肌活性一种非常有效、无创、并具有高空间分辨率、高信号对比(SNR)优势的一项检查技术,cTnI与DE-MRI的联合应用有助于结果的相互应证和互为补充,可更好准确地评价心肌梗死。
Objectives:
The reduce of myocardial perfusion occurs before the electrocardiogram(ECG) changes and clinical syndrome(angina),so myocardial perfusion abnormalities have a positive meaning in the diagnosis of coronary artery disease.The aim of this study is to explore the value of the first-pass myocardial perfusion MR imaging in evaluating the ischemic myocardial perfusion and viability.Especially,to investigate to perfusion curves(time-signal intensity curves) changes of the ischemic myocardium.In addition, to explore the limitations existing in the current MR first-pass perfusion imaging study.
Materials and Methods:
Ten porcine model with myocardial infarction had the preoperative and postoperative MR first-pass myocardial perfusion imaging examination.The perfusion reduce or defects on the MR myocardial perfusion imaging were observed. And the time-signal intensity curves in the regions with the perfusion reduce or defects and normal regions were drawed by the image post-processing software.The peak time,peak signal intensity of curve were statistical analyzed.After MRI examination,the experimental pigs were executed and its heart been had the TTC staining and pathological examination.
Results:
The preoperative myocardial perfusion in the all of the 10 pigs is nomal,but there is myocardial perfusion decrease and defect in 8 experimental pigs after operation.The curves in the area with perfusion defects have no obvious peak and have a sligtly increase in late time.The curves in the area around perfusion defect can be seen the peak,but the peak signal intensity is lower than normal inferior and lateral myocardial wall(P<0.05);and the peak time is delayed compared with normal inferior and lateral myocardial wall(P<0.05).There are myocardial infarction in the perfusion defects areas and its were certified by TTC staining and pathological examination.The interstitial edema and myocardial degeneration can be seen in the perfusion reduced areas.
Conclusion:
MRI fist-pass myocardial perfusion imaging combined with time-signal intensity curves analysis can evaluate perfusion changes of the regional myocardial microcirculation.It may be useful in assessing the ischemic myocardial viability.But there are some limitations in the the clinical application.
Objectives:
Delayed-enhancement MR imaging(DE-MRI) is rapidly becoming a prominent and effective means in the evaluation of myocardial viability,but there is a question about it,that is "bringt is dead"? This study aimed to explore the accuracy and question in assessment of myocardial viability by delayed-enhanced MR imaging.
Materials and Methods
A total of 15 pigs were used to make the acute myocardial infarction(MI) models,and then ten successful models were underwent delayed-enhancement MR imaging at preoperation,]postoperative 24 h,72 h and 1 W,respectively.The hyperenhanced regions and segments as well as their transmural extent on DE-MRI were observed. After MR examination,2,3,5-triphenyltetrazolium chlorid(TTC) staining and pathological examination were performed.The segments with MI detected by the DE-MRI and TTC staning were made statistical analysis.
Results
①Ten MI models were made,and no abnormal signals were found on pre-operative DE-MRI.
②The abnormal high signal myocardial segments were found in the all of 10 pigs after operation on delayed-enhancement MR imaging.There were a total of 30 hyperenhanced segments in ten MI models.And there was no difference in regions and segments with MI between DE-MRI and TTC staining.
③In the judging transmural extent of MI,the results of DE-MRI was correlative with TTC staining(Pearson Chi-Square,P<0.05);and the concordance was good(K>0.75).But the results of two methods was different(McNemar Test,P<0.05). The transmural extent judged by DE-MRI was higher than TTC staining.
④24-hour pathology of high signal area in DE-MRI(myocardial infarction in TTC staining) showed eosinophilic cytoplasm of myocardial cells,homogeneous degeneration,nuclear pyknosis;72-hour pathology showed multifocal myocardial fibers dissoloved irregularly.1-week pathology showed myocardial fibers dissoloved, interstitial fibroblasts and capillary proliferation,small blood vessels congestive.The pathology of slightly higher signal area in DE-MRI(non-infarcion in TTC staining) showed obvious interstitial edema,edema degeneration and balloon-like change of myocardial fibers.
Conclusion:
DE-MRI is an excellent tool for detecting the myocardial infarction.Especially,it can cleary demonstrate the suberdocardial or transmural myocardial infarction.That is very important for the clinical evaluation and treatment of the ischemic heart disease But in the clinical evaluation we should be noted that the bright areas on DE-MRI will may be "zoom" the real areas of myocardial infarction.And we should observe whether are brightness difference in high-intensity zone.
Objectives:
Cardiac troponin(cTnT or cTnI) is regarded as a best marker to determine the acute myocardial injury,In addition,the delayed enhancement MR imaging is becoming the new gold standard in the clinical myocardial viability assessment.This study to explore whether the clinic reagent for detection of the serum cardiac troponin I(cTnI) in the human can be applicable to swine model with acute myocardial infarction;And to investigate the relationships between the cTnl peak value and the degree of myocardial infarction quantificated by delayed-enhancment MR imaging(DE-MRI) and pathological findings.
Materials and Methods
10 successful pig model with acute myocardial infarction were underwent cardiac troponin(cTnI) detection at preoperation,]postoperative 1 h,2 h,after 5 h, 24 h,48 h,72 hours and 1 week;and also were underwent Delayed-Enhancement MR imaging at preoperation,postoperative 24 h,72 h and 1 W,respectively.After MR examination,2,3,5-triphenyltetrazolium chlorid(TTC) staining and immunohistochemistry examination were performed.The degree of myocardial infarction was assessed by DE-MRI and TTC.The cTnI value of 24h after the operation and the degree of myocardial infarction were made correlation analysis.
Results
①The cardiac troponin can be seen raise at 1h after operation,and reached the peak at 24h arfter aperation,then decrease gradually.1 week later the cTnI value return to preoperative levels.
②The segments of myocardial infarction were found in the all of 10 pigs on the immunohistochemistry examination.It displayed:24h group showed HHF35, Myoglobin,Desmin proteins significantly reduced in the infaction region,and pale staining,surrounded by normal myocardial cells with brown staining;72h group showed HHF35,Myoglobin,Desmin protein reduced than 24h group significantly, showed a large region with dyeing missing in the infarction region,and had the clear boundaries with the normal stained brown myocardium,1w group had no significant change compared with 72h group.
③The cTnI peak values of 24h was correlated strongly to the degree of myocardial infarction assessed by TTC(correlation coefficient=0.85,P=0.002) as well as to DE-MRI(correlation coefficient =0.84,P=0.002).The scatter plot shows a clear linear correlation between the cTnI peak values and the degree of myocardial infarction assessed by TTC and DE-MRI.
Conclusion:
The clinical reagent for detection of the serum cardiac troponin I(cTnI) can be applicable to swine model.The cTnI measurement,specially 24h after the operation, can reflects degree of myocardial injury.DE-MRI is currently a very effective, non-invasive technique,and has high spatial resolution in detection of myocardial viability.The cTnI combined with DE-MRI will be more help for clinical work and research in coronary heart disease.
引文
[1]2004 chartbook on cardiovascular Lung and Blood Disease.Bethesda,Md:Natinal Heart,Lung,and Blood Institute;2004
[2]张兆琪.缺血性心脏病磁共振成像.CT与MRI杂志,2003,10(1):56-60.
[3]Fox KAA,Poole-vilson P,Clayton TC,et al.Five-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome.the British heart Foundation RITA-3randomised trial.Lancet,2005,366(9489):914-920
[4]Bastarrika G,Lee YS,Huda W,et al.CT of coronary artery disease.Radiology.2009;253(2):317-338.
[5]van Werkhoven JM,Schuijf JD,Bax JJ.Myocardial perfusion imaging to assess ischemia using multislice computed tomography.Expert Rev Cardiovasc Ther.2009;7(1):49-56.
[6]Pennell DJ,Sechtem UP,Higgins CB,et al.Clinical indications for cardiovascular magnetic resonance(CMR):Consensus Panel report.Eur Heart J.2004;25(21):1940-1965.
[7]Jerosch-Herold M,Seethamraju RT,et al.Analysis of myocardial perfusion MRI.J Magn Reson Imaging.2004;19(6):758-770.
[8]Hunold P,Schlosser T,Barkhausen J.Magnetic resonance cardioiac perfusion imaging-a clinical perspective.Eur Radiol.2006;16(8):1779-1788
[9]朱海云,田建明,王莉等 MR多技术扫描检测活性心肌及其影像学对比的实验研究 临床放射学杂志 2006,25(4):374-378
[10]苗翠莲,张兆琪,王钰等 心肌灌注MRI检测心肌存活的研究 中华放射学杂志2003,36(8):707-711
[11]贾文霄,易化,杨利霞等 磁共振心肌灌注检测猪急性心肌梗死的实验研究.新疆医学大学学报,2008,31(4):365-367
[12]刘庆华,田建明,王莉等 超声、磁共振及核素扫描对心肌早期缺血的比较研究.中国临床医学影像杂志,2005 16(3):144-148
[13]Krombach GA,Kinzel S,Mahnken AH,et al.Minimally invasive close-chest method for creating reperfused or occlusive myocardial infarction in swine.Invest Radiol.2005;40(1):14-18.
[14]Bellamy DD,Pereira RS,McKenzie CA,et al.Gd-DTPA bolus tracking in the myocardium using T1 fast acquisition relaxation Magn Reson Med.2001;46(3):555-564.
[15]Diesbourg LD,PratoES,Wisenberg G,et al.Quantification of myocardial blood flow and extracellular volume using a bolus injection of GD-DTPA:kinetic modeling in canine iskemic disease.Magn Reson Med 1992,23(2):239-253
[16]Nagel E,al-Saadi N,Fleck E.et al.Cardiovascular magnetic resonance:myocardial perfusion.Herz.2000;25(4):409-416.
[17]张兆琪 心血管疾病磁共振成像 人民卫生出版社2007,3:33-34
[18]Higgins C.B,De Roos A主编 程敬亮,张兆琪,张勇主译Cardiovascular MRI and MRA(心血管MRI和MRA)河南科学技术出版社,2008,1:177-178
[19]Sandstede JJ,Lipke C,Beer M,et al.Anaysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocardium on MRI imaging use in the prediction of myocardial viability.AJR,2000,174(6):1737-1740;
[20]Cullen JH,Horsfield MA,Peek CR,et al.Amyocardial perfusion reserve index in humans using first-pass contrast-enhancced magnetic resonance imaging.J Am Coll Cardiol 1999,33(5):1386-1394
[21]Plein S,Radjenovic A,Ridgway JP,et al.Coronary artery disease:myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography.Radiology,2005,235(2):423-430.
[22]Su MY,Lee BC,Wu YW,Yu HY,et al.Perfusion of residual viable myocardium in nontransmural infarct zone after intervention:MR quantitative myocardial blood flow measurement.Radiology.2008 Dec;249(3):820-828.
[23]成官迅 曾弘 张进华等 Gd-DTPA动态增强MRI评价心肌微血管损伤 放射学实践2003 18(8):605-607
[24]Rodrigues de Avila LF,Fernandes JL,et al.Perfusion impairment in patients with normal-appearing coronary arteries:identification with contrast-enhanced MR imaging.Radiology.2006;238(2):464-472.
[25]McCommis KS,Goldstein TA,Zhang H,et al.Quantification of myocardial blood volume during dipyridamole and doubtamine stress:a perfusion CMR study.J Cardiovasc Magn Reson.2007;9(5):785-792.
[26]Kurita T,Sakuma H,Onishi K,et al.Regional myocardial perfusion reserve determined using myocardial perfusion magnetic resonance imaging showed a direct correlation with coronary flow velocity reserve by Doppler flow wire.Eur Heart J.2009 Feb;30(4):444-52.
[27]Bunce NH,Reyes E,Keegan J,et al.Combined coronary and perfusion cardiovascular magnetic resonance for the assessment of coronary artery stenosis.J Cardiovasc Magn Reson.2004;6(2):527-539.
[28]Groothuis JG,Beek AM,Brinckman SL,et al.Low to intermediate probability of coronary artery disease:comparison of coronary CT angiography with first-pass MR myocardial perfusion imaging.Radiology.2010;254(2):384-392.
[29]Mather AN,Lockie T,Nagel E,et al.Appearance of microvascular obstruction on high resolution first-pass perfusion,early and late gadolinium enhancement CMR in patients with acute myocardial infarction.J Cardiovasc Magn Reson.2009 Aug 21;11(1):33.
[30]何金强 叶安培 心脏灌注磁共振成像的图像配准 中国生物医学工程学报 2005 24(2).199-202
[31]Hsu LY,Kellman P,Arai AE.Nonlinear myocardial signal intensity correction improves quantification of contrast-enhanced first-pass MR perfusion in humans.J Magn Reson Imaging.2008 Apr;27(4):793-801.
[32]Jens Vogel-Claussen,MD.Carlos E.Rochitte,MD.Katherine C.Wu,et ah Delayed Enhancement MR Imaging:Utility in Myocardial Assessment1。 Education exhibit 2006,26:875-810
[33]Utz W,Niendorf T,Wassmuth R,et al.Contrast-dose relation in first-pass myocardial MR perfusion imaging.JMagn Reson Imaging.2007;25(6):1131-1135.
[34]Giang TH,Nanz D,Coulden R,et al.Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses:first European multi-centre experience.Eur Heart J.2004 Sep;25(18):1657-1665.
[35]Simonetti OP,Kim RJ,Fieno DS,et al..An improved MR imaging technique for the visualization of myocardial infarction.Radiology 2001;218(1):215-223.
[36]McCommis KS,Goldstein TA,Abendschein DR,et al.Roles of myocardial blood volume and flow in coronary artery disease:an experimental MRI study at rest and during hyperemia.Eur Radiol.2010 Feb 24.
[37] Schmid VJ, Gatehouse PD, Yang GZ. Attenuation resilient AIF estimation based on hierarchical Bayesian modelling for first pass myocardial perfusion MRI. Med Image Comput Comput Assist Interv. 2007;10(Pt 1):393-400.
[38] Ichihara T, Ishida M, Kitagawa K,et al. Quantitative analysis of first-pass contrast-enhanced myocardial perfusion MRI using a Patlak plot method and blood saturation correction. Magn Reson Med. 2009 Aug;62(2):373-383.
[39] Milles J, van der Geest RJ, Jerosch-Herold M,et al. Fully automated motion correction infirst-pass myocardial perfusion MR image sequences. IEEE Trans Med Imaging. 2008 Nov;27(11):1611-1621.
[40] Goldstein TA, Jerosch-Herold M,et al. Fast mapping of myocardial blood flow with MR first-pass perfusion imaging. Magn Reson Med. 2008 Jun;59(6):1394-1400.
[41] Spuentrup E, Ruhl KM, Botnar RM, et al. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model. Circulation. 2009 Apr 7;119(13):1768-1775.
[42] Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation,2000,101(12):1379-1383
[1] Kiss K, Varghese A, Stiskal M,et al. Cardiovascular magnetic resonance: current clinical practice and future potential.Semin Thorac Cardiovasc Surg. 2004 Fall;16(3):235-41.
[2] Constantine G, Shan K, Flamm SD, et al. Role of MRI in clinical cardiology.Lancet 2004;363(9427):2162-22171
[3] Jahnke C, Paetsch I, Schnackenburg B, et al. Coronary MR angiography with steady-state free precession: individually adapted breath-hold technique versus free-breathing technique.Radiology2004;232(3):669-676
[4] Beer M, Machann W, Sandstede J, et al. Energetic difference between viable and non-viable myocardium in patients with recent myocardial infaction are not an effect of differences in wall thinning-a mutivoxel (31)P-MR-spectroscopy and MRI study. Eur Radiol. 2007;17(5):1275-1283
[5] Sakuma H. Magnetic resonance imaging for ischemic heart disease. J Magn Reson Imaging. 2007 ;26(1):3-13.
[6] De Filippo M, Julsrud P, Araoz P,et al. MRI evaluation of myocardial viability. Radiol Med (Torino). 2006 ;111(8):1035-1053
[7] Weidensteiner C, Lanz T, Horn M, et al. Three-dimensional in the isolated infarcted rat heart. J Magn Reson. 2000 ;143(1):17-23.
[8] Weidensteiner C, Horn M, Fekete E,et al. Imaging of intracellular sodium with shift reagent aided (23)Na CSI in isolated rat hearts. Magn Reson Med. 2002 Jul;48(1):89-96.
[9] Horn M, Weidensteiner C, Scheffer H,et al. Use of 23Na MRS to discriminate viable from non viable tissue: experimental studies. MAGMA. 2000 ;11(1-2):42-43.
[10] Horn M, Weidensteiner C, Scheffer H, et al. Detection of myocardial viability based on measurement of sodium content: A (23)Na-NMR study. Magn Reson Med. 2001May;45(5):756-64.
[11] McCommis KS, Goldstein TA, Abendschein DR, et al. Quantification of regional myocardial oxygenation by magnetic resonance imaging: validation with positron emission tomography. Circ Cardiovasc Imaging. 2010 ;3(1):41-46.
[12] Weinsaft JW, Klem I, Judd RM. MRI for the assessment of myocardial viability. Magn Reson Imaging Clin N Am. 2007 ;15(4):505-25.
[13] Jerosch-Herold M, Muehling O, Wilke N. MRI of myocardial perfusion. Semin Ultrasound CT MR.2006;27(1):2-10.
[14] Klem I, Heitner JF, Shah DJ,et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol. 2006 18;47(8):1630-1638
[15] Kim RJ, Fieno DS, Parrish TB,et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.Circulation,1999;100(19):1992-2002
[16] Kwong RY, Chan AK, Brown K, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circuration 2006; 113 (23) :2733-2743
[17] Higuchi T, Nekolla SG, Jankaukas A,et al. Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI. J Nucl Med. 2007 ;48(2):288-94
[18] Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003 ;361(9355):374-379.
[19] Shan K, Constantine G, Sivananthan M,et al.Role of cardiac magnetic resonance imaging in the assessment of myocardial viability circulation 2004; 109(11)1:1328-1334
[20] Pennell DJ, Sechtem UP, Higgins CB,et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004 ;25(21):1940-1965.
[21] Duerinckx AJ.Myocardial viability using MR imaging: is it ready for clinical use?AJR AM J Roentgenol 2000;174:1741-1743.
[22] Beek AM, Kuehl HP, Hofman MB, et al. Delayed contrast-enhanced MRI for the prediction of recovery of function in reperfused acute myocardial infarction:is bringt really dead? Ciculation 2001;104(suppl 17):II-534.
[23] Rehwald WG,Fieno DS, Chen EL, et al.Myocardial magnetic resonance imaging contrast agent concentration after revisible and irrevible ischemic injury.Circuration,2002;105(2) :224-229
[24] Wang L, Zhu HY, Tian JM,et al.Magnetic resonance imaging in determination of myocardial ischemia and viability:comparison with positron emission tomography and single-photon emission computed tomography in a porcine model. Acta Radiol. 2007 Jun;48(5):500-507
[25] Saeed M, Lund G, Wendland MF, et al. Magnetic resonance characterization of the peri-infaction zone of reperfused myocardioal infaction with necrosis-specific and extracellular nonspecific contast media. Circulation,2001,103(6):1083-1089
[26] Klein C,Nekolla SG,Bengel FM, et al.Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging comparison with positron emission tomography. Circulation, 2002,105(2):162-167.
[27] Cerqueira MD, Weissman NJ, Dilsizian V, et al; Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging. 2002 ;18(1):539-542.
[28] Moran GR, Thornhill RE, Sykes J,et al. Myocardial viability imaging using Gd-DTPA: physiological modeling of infracted myocardium, and impact on injection strategy and imaging time. Magn Reson Med. 2002 ;48(5):791-800.
[29] Weidensteiner C, Lanz T, Horn M, et al. Three-dimensional in the isolated infarcted rat heart. J Magn Reson. 2000 ;143(1):17-23.
[30] Weidensteiner C, Horn M, Fekete E,et al. Imaging of intracellular sodium with shift reagent aided (23)Na CSI in isolated rat hearts. Magn Reson Med. 2002 ;48(1):89-96.
[31] Horn M, Weidensteiner C, Scheffer H, et al. Detection of myocardial viability based on measurement of sodium content: A (23)Na-NMR study. Magn Reson Med.2001 ;45(5):756-64.
[32] Gerber BL,Rochitte CE.Bluemke DA, et al. Relation between Gd-DTPA contrast enhancement and regional inotropic reponse in the periphery and center of myocardial infaction. Circulation,2001,104(4):998-1004
[33] Choe YH, Choo KS, Jeon ES, et al. Comparison of MDCT and MRI in the detection and sizing of acute and chronic myocardial infarcts. Eur J Radiol. 2008 May;66(2):292-299.
[34] Kanderian AS, Renapurkar R, Flamm SD. cardial viability and revascularization. Heart Fail Clin. 2009 ;5(3):333-348.
[35]Welinder AE,Wagner GS,Horacek BM,et al.EASI-Derived vs standard 12-lead electrocardiogram for Selvester QRS score estimations of chronic myocardial infarct size,using cardiac magnetic resonance imaging as gold standard.MyoJ Electrocardiol.2009;42(2):145-151.
[36]Desjardins B,Crawford T,Good E,et al..Infarct architecture and characteristics on delayed enhanced magnetic resonance imaging and electroanatomic mapping in patients with postinfarction ventricular arrhythmia.Heart Rhythm.2009;6(5):644-51.
[37]陈穗惠,高元桂,安宁豫等 磁共振延迟扫描冠心病的诊断价值 中华老年病心血管杂志 2003 5(5):303-306
[38]Kim HW,Klem I,Shah DJ,et al.Unrecognized non-Q-wave myocardial infarction:prevalence and prognostic significance in patients with suspected coronary disease.PLOS Med.2009 6(4):e 1000057
[39]Thornhill RE,Prato FS,Wisenberg G.The assessment of myocardial viability:a review of current diagnostic imaging approaches.J Cardiovasc Magn Reson.2002;4(3):381-410.
[40]Flacke SJ,Fischer SE,Lorenz CH.Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo:normal distribution and elevation in acute and chronic infarction.Radiology,2001,218(3):703-710。
[41]Fieno DS,Kim RJ,Chen EL,et al.Contrast-enhanced magnetic resonce imaging of myocardium at risk:distinction between resersible and irreversible injury througuout infact healing.J Am Cardiol,2000,36:1985-1991;
[42]Oshinski JN,Yang Z,Jones JR,et al.Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging.Circulation 2001;104(23):2838-2842。
[43]Bogaert J,Dymarkowski S.Delayed contrast-enhanced MRI:use in myocardial viability assessment and other cardiac pathology.Eur Radiol,2005,15[suppl 2]:52-58
[44]Hunold P,Schlosser T,Vogt FM,et al.Myocardial late enhancement in contrast-enhanced cardiac MRI:distinction between infaction scar and non-infarction-related disease.AIR,2005,184(5):1420-1426;
[45]Stork A,Mullerleile K,Bansmann PM,et al..Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies.Rofo.2007 Jan;179(1):21-30.
[46] Vogel-Claussen J,Rochitte CE, Wu KC, et al. Delayed enhancement MR imaging:utility in myocardial assessment Radiographics 2006;26:795-810
[47] Krittayaphong R, Saiviroonporn P, Boonyasirinant T, et al. Accuracy of visual assessment in the detection and quantification of myocardial scar by delayed enhancement magnetic resonance imaging. J Med Assoc Thai. 2007 ;90 Suppl 2:1-8.
[48] Nilsson JC, Nielsen G, Groenning BA, et al. Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging. Heart. 2001 ;85(6):639-642.
[1] Bax JJ, Pattern JA, Poldermans D,et al. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications. Semin Nucl Med. 2000 Oct;30(4):281-98.
[2] Fishbein MC, Meerbaum S, Rit J, Lando U, et al.Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J. 1981 ;101(5):593-600.
[3] Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000 ;36(3):959-69.
[4] Braunwald E,.Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina).Circulation. 2000 ;102(10):1193-209.
[5] Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With UnstableAngina). Circulation. 2002;106(14):1893-900.
[6] Weinsaft JW, Klem I, Judd RM. MRI for the assessment of myocardial viability. Magn Reson Imaging Clin N Am. 2007 ;15(4):505-25.
[7] Shan K, Constantine G, Sivananthan M,et al.Role of cardiac magnetic resonance imaging in the assessment of myocardial viability circulation 2004;109(11)1:1328-1334
[8] Kanderian AS, Renapurkar R, Flamm SD. cardial viability and revascularization. Heart Fail Clin. 2009 ;5(3):333-48.
[9] Hedstrom E, Astrom-Olsson K, Ohlin H, et al. Peak CKMB and cTnT accurately estimates myocardial infarct size after reperfusion. Scand Cardiovasc J. 2007 Jan;41(1):44-50.
[10] B0hmer E, Hoffmann P, Abdelnoor M, et al. Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months. Cardiology. 2009;113(3):207-12. Epub 2009 Feb 14.
[11] White FC, Carroll SM, Magnet A et al.Coronary collateral development in swine after coronary artery occlusion. Circ Res. 1992 Dec;71 (6): 1490-1500.
[12] Cummins P, Young A, Auckland ML, Michie CA, Stone PC, Shepstone BJ. Comparison of serum cardiac specific troponin-I with creatine kinase, creatine kinase-MB isoenzyme, tropomyosin, myoglobin and C-reactive protein release in marathon runners: cardiac or skeletal muscle trauma? Eur J Clin Invest. 1987;17(4):317-324.
[13] Adams JE, Bodor GS, Davila-Roman VG et al. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation,1993,88(1):101-106.
[14] Katus HA, Looser S, Hallermaher K, et al. Development and in vitro characterization of a : new immunoassay of cardiac troponinT. Clin Chem,1992,38:386-393.
[15] Collinson PO, Gaze DC, Morris F, et al. Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria. Ann Clin Biochem. 2006 Jul;43(Pt 4):273-80.
[16] Pasierski TJ, Alton MA, Pearson AC, et al. Transesophaged echocardiograhic characterization of pulmonary vein flow not due to atrial contraction or mitral regurgitation. Am J Cardiol. 1991 68(4):415-418.
[17] Kwong RY, Chan AK, Brown K, et al. Impact of unrecognized myocardial scar detected bycardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circuration 2006; 113 (23) :2733-2743 。
[18] Omura T, Teragaki M, Tani T, Yamagishi H, et al. Estimation of infarct size using serum troponin T concentration in patients with acute myocardial infarction. Jpn Circ J. 1993 57(11):1062-1070.
[19] Katus HA, Remppis A, Scheffold T, et al. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol. 1991;67(16):1360-1367.
[20] Neizel M, Futterer S, Steen H, et al. Predicting microvascular obstruction with cardiac troponin T after acute myocardial infarction: a correlative study with contrast-enhanced magnetic resonance imaging. Clin Res Cardiol. 2009 Sep;98(9):555-62. Epub 2009 Jul 7.
[21] Bogaert J, Dymarkowski S.Delayed contrast-enhanced MRI:use in myocardial assessment and other cardiac pathology. Eur Radiol,2005,15[suppl 2]:52-58
[22] Hunold P, Schlosser T, Vogt FM, et al. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infaction scar and non-infarction-related disease. AIR,2005,184(5):1420-1426;
[23] Stork A, Mullerleile K, Bansmann PM, et al.. Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies. Rofo. 2007 Jan;179(1):21-30.
[24] Vogel-Claussen J,Rochitte CE, Wu KC, et al. Delayed enhancement MR imaging:utility in myocardial assessment Radiographics 2006;26:795-810
[25] Peivandi AA, Dahm M, Hake U, et al. Patterns and diagnostic value of cardiac troponin I vs. troponin T and CKMB after OPCAB surgery. Thorac Cardiovasc Surg. 2001 Jun;49(3):137-43.
[1]张兆琪.缺血性心脏病磁共振成像.CT与MRI杂志,2003,10(1):56-60.
[2]Fox KAA,Poole-vilson P,Clayton TC,et al.Five-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome.the British heart Foundation RITA-3randomised trial.Lancet,2005,366(9489):914-920
[3]Constantine G,Shan K,Flamm SD,et al.Role of MRI in clinical cardiology.Lancet 2004;363(9427):2162-22171
[4]Jahnke C,Paetsch I,Schnackenburg B,et al.Coronary MR angiography with steady-state free precession:individually adapted breath-hold technique versus free-breathing technique.Radiology2004;232(3):669-676
[5]Beer M,Machann W,Sandstede J,et al.Energetic difference between viable and non-viable myocardium in patients with recent myocardial infaction are not an effect of differences in wall thinning-a mutivoxel(31)P-MR-spectroscopy and MRI study.Eur Radiol.2007;17(5):1275-1283
[6]De Filippo M,Julsrud P,Araoz P,et al.MRI evaluation of myocardial viability.Radiol Med (Torino).2006;111(8):1035-1053
[7]Weidensteiner C,Lanz T,Horn M,et al.Three-dimensional in the isolated infarcted rat heart.JMagn Reson.2000;143(1):17-23.
[8]Weidensteiner C,Horn M,Fekete E,et al.Imaging of intracellular sodium with shift reagent aided(23)Na CSI in isolated rat hearts.Magn Reson Med.2002 Jul;48(1):89-96.
[9]Horn M,Weidensteiner C,Scheffer H,et al.Use of 23Na MRS to discriminate viable from non viable tissue:experimental studies.MAGMA.2000;11(1-2):42-3.
[10]Horn M,Weidensteiner C,Scheffer H,et al.Detection of myocardial viability based on measurement of sodium content:A(23)Na-NMR study.Magn Reson Med.2001May;45(5):756-64.
[11]McCommis KS,Goldstein TA,Abendschein DR,et al.Quantification of regional myocardial oxygenation by magnetic resonance imaging:validation with positron emission tomography.Circ Cardiovasc Imaging.2010;3(1):41-46.
[12]Weinsaft JW,Klem I,Judd RM.MRI for the assessment of myocardial viability.Magn Reson Imaging Clin N Am.2007;15(4):505-25.
[13] Kim RJ, Fieno DS, Parrish TB,et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation,1999;100(19):1992-2002
[14] Shan K, Constantine G, Sivananthan M,et al.Role of cardiac magnetic resonance imaging in the assessment of myocardial viability circulation 2004;109(11)1:1328-1334
[15] Moran GR, Thornhill RE, Sykes J,et al. Myocardial viability imaging using Gd-DTPA: physiological modeling of infracted myocardium, and impact on injection strategy and imaging time. Magn Reson Med. 2002 ;48(5):791-800.
[16] Beer M, Machann W, Sandstede J, et al. Energetic difference between viable and non-viable myocardium in patients with recent myocardial infaction are not an effect of differences in wall thinning-a mutivoxel (31)P-MR-spectroscopy and MRI study. Eur Radiol. 2007;17(5):1275-1283
[17] Weidensteiner C, Lanz T, Horn M, et al. Three-dimensional in the isolated infarcted rat heart. J Magn Reson. 2000 ;143(1):17-23.
[18] Weidensteiner C, Horn M, Fekete E,et al. Imaging of intracellular sodium with shift reagent aided (23)Na CSI in isolated rat hearts. Magn Reson Med. 2002 ;48(1):89-96.
[19] Horn M, Weidensteiner C, Scheffer H, et al. Detection of myocardial viability based on measurement of sodium content: A (23)Na-NMR study. Magn Reson Med. 2001 ;45(5):756-64.
[20] McCommis KS, Goldstein TA, Abendschein DR, et al. Quantification of regional myocardial oxygenation by magnetic resonance imaging: validation with positron emission tomography. Circ Cardiovasc Imaging. 2010 ;3(1):41-46.
[21] Kwong RY, Chan AK, Brown K, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circuration 2006; 113 (23) :2733-2743
[22] Rehwald WG,Fieno DS, Chen EL, et al.Myocardial magnetic resonance imaging contrast agent concentration after revisible and irrevible ischemic injury.Circuration,2002;105 (2) :224-229
[23] Higuchi T, Nekolla SG, Jankaukas A,et al. Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI. J Nucl Med. 2007 ;48(2):288-94
[24] Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003 ;361(9355):374-379.
[25] Klein C,Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast enhanced magnetic resonance imagingxomparison with positron emission tomography. Circulation,2002,105(2): 162-167
[26] Wang L, Zhu HY, Tian JM,et al.Magnetic resonance imaging in determination of myocardial ischemia and viabilityxomparison with positron emission tomography and single-photon emission computed tomography in a porcine model. Acta Radiol. 2007 Jun;48(5):500-507
[27] Kanderian AS, Renapurkar R, Flamm SD. Myocardial viability and revascularization. Heart fail Clin. 2009 ;5(3):333-48.
[28] Jerosch-Herold M, Muehling O, Wilke N. MRI of myocardial perfusion. Semin Ultrasound CT MR.2006;27(1):2-10.
[29] Sakuma H. Magnetic resonance imaging for ischemic heart diasease.J Magn Reson Imaging.2007 26(1):3-13
[30] Thornhill RE, Prato FS, Wisenberg G. The assessment of myocardial viability: a review of current diagnostic imaging approaches. J Cardiovasc Magn Reson. 2002;4(3):381-410.
[31] Gerber BL,Garot J, Bluemke DA, et al. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction.Circulation.2002;106(9):1083-1089
[32] Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation,2004,109( 18):2172-2174
[33] Ogawa M, Doi K, Fukumoto A,et al. Reverse-remodeling after coronary artery bypass grafting in ischemic cardiomyopathy: assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons.Interact Cardiovasc Thorac Surg. 2007 ;6(5):673-675
[34] Ogawa M, Doi K, Yamada Y, et al. Surgical ventricular restoration based on evaluation of myocardial viability withdelayed-enhanced magnetic resonance imaging.Gen Thorac Cardiovasc Surg. 2007 ;55(4):149-57
[35] Suh WM, Fowler SJ, Wallis JB, et al. Utility of cardiac MRI in guiding revascularization therapy in unprotected left main stenosis: a case report.Cardiovasc Revasc Med. 2007 Jul-Sep;8(3):209-12
[36] Selvanayagam JB,Kardos A, Francis JM, et al.Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularison. Circulation 2004.110(12):1535-1541
[37] Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.N Engl J Med.2000,343(20):1445-1453
[38] Kitagawa K,Sakuma H, HiranoT, et al. Acute myocardial infarction:myocardial viability assessment in patients early therafter comparison of contrast-enhanced MR imaging with resting(201)TI SPECT.single . photon emission computed tomography. Radiology,2003,226(1):138-144
[39] Kuhl HP, Beek AM, van der Weerdt AP, et al. Myocarial viability in chronic ischemic heart diasease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol,2003,41(8):1341-1348
[40] Cheong BY, Muthupillai R, Wilson JM, et al. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation. 2009 Nov 24;120(21):2069-76. Epub 2009 Nov 9.
[41] Yan AT, Shayne AJ, Brown KA, et al. Characterization of peri-infarct zone by contrast enhanced cardiac magnetic resonance imaging is a pownful predictor of post-myocardial infarction mortality. Circulation 2006;114(1):32-39
[42] Duffy KJ, Ferrari VA.Prognosis following acute myocardial infarction: insights from cardiovascularmagnetic resonance. Curr Cardiol Rep. 2007 ;9(1):57-62
[43] Beeres SL, Bengel FM, Bartunek J,et-al. Role of imaging in cardiac stem cell therapy. J Am Coll Cardiol.2007 Mar 20;49(11):1137-48. 2007;49(11):1137-1148
[44] Dick AJ, Guttman MA, Raman VK, et-al.Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in Swine.Circulation. 2003 ;108(23):2899-2904
[45] Fieno DS,Kim RJ,Chen EL, et al. Contrast-enhanced magnetic resonce imaging of myocardium at risk:distinction between resersible and irreversible injury througuout infact healing. J Am Cardiol,2000,36:1985-1991
[46] Oshinski JN, Yang Z, Jones JR., et al. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001; 104 (23) :2838-2842
[47] Saeed M, Lund G, Wendland MF, et al. Magnetic resonance characterization of the peri-infaction zone of reperfused myocardioal infaction with necrosis-specific and extracellular nonspecific contast media. Circulation,2001,103(6):1083-1089
[48] Nguyen TD, Spincemaille P, Weinsaft JW, et al. A fast navigator-gated 3D sequence for delayed enhancement MRI of the myocardium: comparison with breathhold 2D imaging. J Magn Reson Imaging. 2008 Apr;27(4):802-8.
[2]张兆琪.缺血性心脏病磁共振成像.CT与MRI杂志,2003,10(1):56-60.
[3]Fox KAA,Poole-vilson P,Clayton TC,et al.Five-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome.the British heart Foundation RITA-3randomised trial.Lancet,2005,366(9489):914-920
[4]Bastarrika G,Lee YS,Huda W,et al.CT of coronary artery disease.Radiology.2009;253(2):317-338.
[5]van Werkhoven JM,Schuijf JD,Bax JJ.Myocardial perfusion imaging to assess ischemia using multislice computed tomography.Expert Rev Cardiovasc Ther.2009;7(1):49-56.
[6]Pennell DJ,Sechtem UP,Higgins CB,et al.Clinical indications for cardiovascular magnetic resonance(CMR):Consensus Panel report.Eur Heart J.2004;25(21):1940-1965.
[7]Jerosch-Herold M,Seethamraju RT,et al.Analysis of myocardial perfusion MRI.J Magn Reson Imaging.2004;19(6):758-770.
[8]Hunold P,Schlosser T,Barkhausen J.Magnetic resonance cardioiac perfusion imaging-a clinical perspective.Eur Radiol.2006;16(8):1779-1788
[9]朱海云,田建明,王莉等 MR多技术扫描检测活性心肌及其影像学对比的实验研究 临床放射学杂志 2006,25(4):374-378
[10]苗翠莲,张兆琪,王钰等 心肌灌注MRI检测心肌存活的研究 中华放射学杂志2003,36(8):707-711
[11]贾文霄,易化,杨利霞等 磁共振心肌灌注检测猪急性心肌梗死的实验研究.新疆医学大学学报,2008,31(4):365-367
[12]刘庆华,田建明,王莉等 超声、磁共振及核素扫描对心肌早期缺血的比较研究.中国临床医学影像杂志,2005 16(3):144-148
[13]Krombach GA,Kinzel S,Mahnken AH,et al.Minimally invasive close-chest method for creating reperfused or occlusive myocardial infarction in swine.Invest Radiol.2005;40(1):14-18.
[14]Bellamy DD,Pereira RS,McKenzie CA,et al.Gd-DTPA bolus tracking in the myocardium using T1 fast acquisition relaxation Magn Reson Med.2001;46(3):555-564.
[15]Diesbourg LD,PratoES,Wisenberg G,et al.Quantification of myocardial blood flow and extracellular volume using a bolus injection of GD-DTPA:kinetic modeling in canine iskemic disease.Magn Reson Med 1992,23(2):239-253
[16]Nagel E,al-Saadi N,Fleck E.et al.Cardiovascular magnetic resonance:myocardial perfusion.Herz.2000;25(4):409-416.
[17]张兆琪 心血管疾病磁共振成像 人民卫生出版社2007,3:33-34
[18]Higgins C.B,De Roos A主编 程敬亮,张兆琪,张勇主译Cardiovascular MRI and MRA(心血管MRI和MRA)河南科学技术出版社,2008,1:177-178
[19]Sandstede JJ,Lipke C,Beer M,et al.Anaysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocardium on MRI imaging use in the prediction of myocardial viability.AJR,2000,174(6):1737-1740;
[20]Cullen JH,Horsfield MA,Peek CR,et al.Amyocardial perfusion reserve index in humans using first-pass contrast-enhancced magnetic resonance imaging.J Am Coll Cardiol 1999,33(5):1386-1394
[21]Plein S,Radjenovic A,Ridgway JP,et al.Coronary artery disease:myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography.Radiology,2005,235(2):423-430.
[22]Su MY,Lee BC,Wu YW,Yu HY,et al.Perfusion of residual viable myocardium in nontransmural infarct zone after intervention:MR quantitative myocardial blood flow measurement.Radiology.2008 Dec;249(3):820-828.
[23]成官迅 曾弘 张进华等 Gd-DTPA动态增强MRI评价心肌微血管损伤 放射学实践2003 18(8):605-607
[24]Rodrigues de Avila LF,Fernandes JL,et al.Perfusion impairment in patients with normal-appearing coronary arteries:identification with contrast-enhanced MR imaging.Radiology.2006;238(2):464-472.
[25]McCommis KS,Goldstein TA,Zhang H,et al.Quantification of myocardial blood volume during dipyridamole and doubtamine stress:a perfusion CMR study.J Cardiovasc Magn Reson.2007;9(5):785-792.
[26]Kurita T,Sakuma H,Onishi K,et al.Regional myocardial perfusion reserve determined using myocardial perfusion magnetic resonance imaging showed a direct correlation with coronary flow velocity reserve by Doppler flow wire.Eur Heart J.2009 Feb;30(4):444-52.
[27]Bunce NH,Reyes E,Keegan J,et al.Combined coronary and perfusion cardiovascular magnetic resonance for the assessment of coronary artery stenosis.J Cardiovasc Magn Reson.2004;6(2):527-539.
[28]Groothuis JG,Beek AM,Brinckman SL,et al.Low to intermediate probability of coronary artery disease:comparison of coronary CT angiography with first-pass MR myocardial perfusion imaging.Radiology.2010;254(2):384-392.
[29]Mather AN,Lockie T,Nagel E,et al.Appearance of microvascular obstruction on high resolution first-pass perfusion,early and late gadolinium enhancement CMR in patients with acute myocardial infarction.J Cardiovasc Magn Reson.2009 Aug 21;11(1):33.
[30]何金强 叶安培 心脏灌注磁共振成像的图像配准 中国生物医学工程学报 2005 24(2).199-202
[31]Hsu LY,Kellman P,Arai AE.Nonlinear myocardial signal intensity correction improves quantification of contrast-enhanced first-pass MR perfusion in humans.J Magn Reson Imaging.2008 Apr;27(4):793-801.
[32]Jens Vogel-Claussen,MD.Carlos E.Rochitte,MD.Katherine C.Wu,et ah Delayed Enhancement MR Imaging:Utility in Myocardial Assessment1。 Education exhibit 2006,26:875-810
[33]Utz W,Niendorf T,Wassmuth R,et al.Contrast-dose relation in first-pass myocardial MR perfusion imaging.JMagn Reson Imaging.2007;25(6):1131-1135.
[34]Giang TH,Nanz D,Coulden R,et al.Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses:first European multi-centre experience.Eur Heart J.2004 Sep;25(18):1657-1665.
[35]Simonetti OP,Kim RJ,Fieno DS,et al..An improved MR imaging technique for the visualization of myocardial infarction.Radiology 2001;218(1):215-223.
[36]McCommis KS,Goldstein TA,Abendschein DR,et al.Roles of myocardial blood volume and flow in coronary artery disease:an experimental MRI study at rest and during hyperemia.Eur Radiol.2010 Feb 24.
[37] Schmid VJ, Gatehouse PD, Yang GZ. Attenuation resilient AIF estimation based on hierarchical Bayesian modelling for first pass myocardial perfusion MRI. Med Image Comput Comput Assist Interv. 2007;10(Pt 1):393-400.
[38] Ichihara T, Ishida M, Kitagawa K,et al. Quantitative analysis of first-pass contrast-enhanced myocardial perfusion MRI using a Patlak plot method and blood saturation correction. Magn Reson Med. 2009 Aug;62(2):373-383.
[39] Milles J, van der Geest RJ, Jerosch-Herold M,et al. Fully automated motion correction infirst-pass myocardial perfusion MR image sequences. IEEE Trans Med Imaging. 2008 Nov;27(11):1611-1621.
[40] Goldstein TA, Jerosch-Herold M,et al. Fast mapping of myocardial blood flow with MR first-pass perfusion imaging. Magn Reson Med. 2008 Jun;59(6):1394-1400.
[41] Spuentrup E, Ruhl KM, Botnar RM, et al. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model. Circulation. 2009 Apr 7;119(13):1768-1775.
[42] Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation,2000,101(12):1379-1383
[1] Kiss K, Varghese A, Stiskal M,et al. Cardiovascular magnetic resonance: current clinical practice and future potential.Semin Thorac Cardiovasc Surg. 2004 Fall;16(3):235-41.
[2] Constantine G, Shan K, Flamm SD, et al. Role of MRI in clinical cardiology.Lancet 2004;363(9427):2162-22171
[3] Jahnke C, Paetsch I, Schnackenburg B, et al. Coronary MR angiography with steady-state free precession: individually adapted breath-hold technique versus free-breathing technique.Radiology2004;232(3):669-676
[4] Beer M, Machann W, Sandstede J, et al. Energetic difference between viable and non-viable myocardium in patients with recent myocardial infaction are not an effect of differences in wall thinning-a mutivoxel (31)P-MR-spectroscopy and MRI study. Eur Radiol. 2007;17(5):1275-1283
[5] Sakuma H. Magnetic resonance imaging for ischemic heart disease. J Magn Reson Imaging. 2007 ;26(1):3-13.
[6] De Filippo M, Julsrud P, Araoz P,et al. MRI evaluation of myocardial viability. Radiol Med (Torino). 2006 ;111(8):1035-1053
[7] Weidensteiner C, Lanz T, Horn M, et al. Three-dimensional in the isolated infarcted rat heart. J Magn Reson. 2000 ;143(1):17-23.
[8] Weidensteiner C, Horn M, Fekete E,et al. Imaging of intracellular sodium with shift reagent aided (23)Na CSI in isolated rat hearts. Magn Reson Med. 2002 Jul;48(1):89-96.
[9] Horn M, Weidensteiner C, Scheffer H,et al. Use of 23Na MRS to discriminate viable from non viable tissue: experimental studies. MAGMA. 2000 ;11(1-2):42-43.
[10] Horn M, Weidensteiner C, Scheffer H, et al. Detection of myocardial viability based on measurement of sodium content: A (23)Na-NMR study. Magn Reson Med. 2001May;45(5):756-64.
[11] McCommis KS, Goldstein TA, Abendschein DR, et al. Quantification of regional myocardial oxygenation by magnetic resonance imaging: validation with positron emission tomography. Circ Cardiovasc Imaging. 2010 ;3(1):41-46.
[12] Weinsaft JW, Klem I, Judd RM. MRI for the assessment of myocardial viability. Magn Reson Imaging Clin N Am. 2007 ;15(4):505-25.
[13] Jerosch-Herold M, Muehling O, Wilke N. MRI of myocardial perfusion. Semin Ultrasound CT MR.2006;27(1):2-10.
[14] Klem I, Heitner JF, Shah DJ,et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol. 2006 18;47(8):1630-1638
[15] Kim RJ, Fieno DS, Parrish TB,et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.Circulation,1999;100(19):1992-2002
[16] Kwong RY, Chan AK, Brown K, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circuration 2006; 113 (23) :2733-2743
[17] Higuchi T, Nekolla SG, Jankaukas A,et al. Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI. J Nucl Med. 2007 ;48(2):288-94
[18] Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003 ;361(9355):374-379.
[19] Shan K, Constantine G, Sivananthan M,et al.Role of cardiac magnetic resonance imaging in the assessment of myocardial viability circulation 2004; 109(11)1:1328-1334
[20] Pennell DJ, Sechtem UP, Higgins CB,et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004 ;25(21):1940-1965.
[21] Duerinckx AJ.Myocardial viability using MR imaging: is it ready for clinical use?AJR AM J Roentgenol 2000;174:1741-1743.
[22] Beek AM, Kuehl HP, Hofman MB, et al. Delayed contrast-enhanced MRI for the prediction of recovery of function in reperfused acute myocardial infarction:is bringt really dead? Ciculation 2001;104(suppl 17):II-534.
[23] Rehwald WG,Fieno DS, Chen EL, et al.Myocardial magnetic resonance imaging contrast agent concentration after revisible and irrevible ischemic injury.Circuration,2002;105(2) :224-229
[24] Wang L, Zhu HY, Tian JM,et al.Magnetic resonance imaging in determination of myocardial ischemia and viability:comparison with positron emission tomography and single-photon emission computed tomography in a porcine model. Acta Radiol. 2007 Jun;48(5):500-507
[25] Saeed M, Lund G, Wendland MF, et al. Magnetic resonance characterization of the peri-infaction zone of reperfused myocardioal infaction with necrosis-specific and extracellular nonspecific contast media. Circulation,2001,103(6):1083-1089
[26] Klein C,Nekolla SG,Bengel FM, et al.Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging comparison with positron emission tomography. Circulation, 2002,105(2):162-167.
[27] Cerqueira MD, Weissman NJ, Dilsizian V, et al; Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging. 2002 ;18(1):539-542.
[28] Moran GR, Thornhill RE, Sykes J,et al. Myocardial viability imaging using Gd-DTPA: physiological modeling of infracted myocardium, and impact on injection strategy and imaging time. Magn Reson Med. 2002 ;48(5):791-800.
[29] Weidensteiner C, Lanz T, Horn M, et al. Three-dimensional in the isolated infarcted rat heart. J Magn Reson. 2000 ;143(1):17-23.
[30] Weidensteiner C, Horn M, Fekete E,et al. Imaging of intracellular sodium with shift reagent aided (23)Na CSI in isolated rat hearts. Magn Reson Med. 2002 ;48(1):89-96.
[31] Horn M, Weidensteiner C, Scheffer H, et al. Detection of myocardial viability based on measurement of sodium content: A (23)Na-NMR study. Magn Reson Med.2001 ;45(5):756-64.
[32] Gerber BL,Rochitte CE.Bluemke DA, et al. Relation between Gd-DTPA contrast enhancement and regional inotropic reponse in the periphery and center of myocardial infaction. Circulation,2001,104(4):998-1004
[33] Choe YH, Choo KS, Jeon ES, et al. Comparison of MDCT and MRI in the detection and sizing of acute and chronic myocardial infarcts. Eur J Radiol. 2008 May;66(2):292-299.
[34] Kanderian AS, Renapurkar R, Flamm SD. cardial viability and revascularization. Heart Fail Clin. 2009 ;5(3):333-348.
[35]Welinder AE,Wagner GS,Horacek BM,et al.EASI-Derived vs standard 12-lead electrocardiogram for Selvester QRS score estimations of chronic myocardial infarct size,using cardiac magnetic resonance imaging as gold standard.MyoJ Electrocardiol.2009;42(2):145-151.
[36]Desjardins B,Crawford T,Good E,et al..Infarct architecture and characteristics on delayed enhanced magnetic resonance imaging and electroanatomic mapping in patients with postinfarction ventricular arrhythmia.Heart Rhythm.2009;6(5):644-51.
[37]陈穗惠,高元桂,安宁豫等 磁共振延迟扫描冠心病的诊断价值 中华老年病心血管杂志 2003 5(5):303-306
[38]Kim HW,Klem I,Shah DJ,et al.Unrecognized non-Q-wave myocardial infarction:prevalence and prognostic significance in patients with suspected coronary disease.PLOS Med.2009 6(4):e 1000057
[39]Thornhill RE,Prato FS,Wisenberg G.The assessment of myocardial viability:a review of current diagnostic imaging approaches.J Cardiovasc Magn Reson.2002;4(3):381-410.
[40]Flacke SJ,Fischer SE,Lorenz CH.Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo:normal distribution and elevation in acute and chronic infarction.Radiology,2001,218(3):703-710。
[41]Fieno DS,Kim RJ,Chen EL,et al.Contrast-enhanced magnetic resonce imaging of myocardium at risk:distinction between resersible and irreversible injury througuout infact healing.J Am Cardiol,2000,36:1985-1991;
[42]Oshinski JN,Yang Z,Jones JR,et al.Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging.Circulation 2001;104(23):2838-2842。
[43]Bogaert J,Dymarkowski S.Delayed contrast-enhanced MRI:use in myocardial viability assessment and other cardiac pathology.Eur Radiol,2005,15[suppl 2]:52-58
[44]Hunold P,Schlosser T,Vogt FM,et al.Myocardial late enhancement in contrast-enhanced cardiac MRI:distinction between infaction scar and non-infarction-related disease.AIR,2005,184(5):1420-1426;
[45]Stork A,Mullerleile K,Bansmann PM,et al..Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies.Rofo.2007 Jan;179(1):21-30.
[46] Vogel-Claussen J,Rochitte CE, Wu KC, et al. Delayed enhancement MR imaging:utility in myocardial assessment Radiographics 2006;26:795-810
[47] Krittayaphong R, Saiviroonporn P, Boonyasirinant T, et al. Accuracy of visual assessment in the detection and quantification of myocardial scar by delayed enhancement magnetic resonance imaging. J Med Assoc Thai. 2007 ;90 Suppl 2:1-8.
[48] Nilsson JC, Nielsen G, Groenning BA, et al. Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging. Heart. 2001 ;85(6):639-642.
[1] Bax JJ, Pattern JA, Poldermans D,et al. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications. Semin Nucl Med. 2000 Oct;30(4):281-98.
[2] Fishbein MC, Meerbaum S, Rit J, Lando U, et al.Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J. 1981 ;101(5):593-600.
[3] Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000 ;36(3):959-69.
[4] Braunwald E,.Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina).Circulation. 2000 ;102(10):1193-209.
[5] Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With UnstableAngina). Circulation. 2002;106(14):1893-900.
[6] Weinsaft JW, Klem I, Judd RM. MRI for the assessment of myocardial viability. Magn Reson Imaging Clin N Am. 2007 ;15(4):505-25.
[7] Shan K, Constantine G, Sivananthan M,et al.Role of cardiac magnetic resonance imaging in the assessment of myocardial viability circulation 2004;109(11)1:1328-1334
[8] Kanderian AS, Renapurkar R, Flamm SD. cardial viability and revascularization. Heart Fail Clin. 2009 ;5(3):333-48.
[9] Hedstrom E, Astrom-Olsson K, Ohlin H, et al. Peak CKMB and cTnT accurately estimates myocardial infarct size after reperfusion. Scand Cardiovasc J. 2007 Jan;41(1):44-50.
[10] B0hmer E, Hoffmann P, Abdelnoor M, et al. Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months. Cardiology. 2009;113(3):207-12. Epub 2009 Feb 14.
[11] White FC, Carroll SM, Magnet A et al.Coronary collateral development in swine after coronary artery occlusion. Circ Res. 1992 Dec;71 (6): 1490-1500.
[12] Cummins P, Young A, Auckland ML, Michie CA, Stone PC, Shepstone BJ. Comparison of serum cardiac specific troponin-I with creatine kinase, creatine kinase-MB isoenzyme, tropomyosin, myoglobin and C-reactive protein release in marathon runners: cardiac or skeletal muscle trauma? Eur J Clin Invest. 1987;17(4):317-324.
[13] Adams JE, Bodor GS, Davila-Roman VG et al. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation,1993,88(1):101-106.
[14] Katus HA, Looser S, Hallermaher K, et al. Development and in vitro characterization of a : new immunoassay of cardiac troponinT. Clin Chem,1992,38:386-393.
[15] Collinson PO, Gaze DC, Morris F, et al. Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria. Ann Clin Biochem. 2006 Jul;43(Pt 4):273-80.
[16] Pasierski TJ, Alton MA, Pearson AC, et al. Transesophaged echocardiograhic characterization of pulmonary vein flow not due to atrial contraction or mitral regurgitation. Am J Cardiol. 1991 68(4):415-418.
[17] Kwong RY, Chan AK, Brown K, et al. Impact of unrecognized myocardial scar detected bycardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circuration 2006; 113 (23) :2733-2743 。
[18] Omura T, Teragaki M, Tani T, Yamagishi H, et al. Estimation of infarct size using serum troponin T concentration in patients with acute myocardial infarction. Jpn Circ J. 1993 57(11):1062-1070.
[19] Katus HA, Remppis A, Scheffold T, et al. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol. 1991;67(16):1360-1367.
[20] Neizel M, Futterer S, Steen H, et al. Predicting microvascular obstruction with cardiac troponin T after acute myocardial infarction: a correlative study with contrast-enhanced magnetic resonance imaging. Clin Res Cardiol. 2009 Sep;98(9):555-62. Epub 2009 Jul 7.
[21] Bogaert J, Dymarkowski S.Delayed contrast-enhanced MRI:use in myocardial assessment and other cardiac pathology. Eur Radiol,2005,15[suppl 2]:52-58
[22] Hunold P, Schlosser T, Vogt FM, et al. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infaction scar and non-infarction-related disease. AIR,2005,184(5):1420-1426;
[23] Stork A, Mullerleile K, Bansmann PM, et al.. Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies. Rofo. 2007 Jan;179(1):21-30.
[24] Vogel-Claussen J,Rochitte CE, Wu KC, et al. Delayed enhancement MR imaging:utility in myocardial assessment Radiographics 2006;26:795-810
[25] Peivandi AA, Dahm M, Hake U, et al. Patterns and diagnostic value of cardiac troponin I vs. troponin T and CKMB after OPCAB surgery. Thorac Cardiovasc Surg. 2001 Jun;49(3):137-43.
[1]张兆琪.缺血性心脏病磁共振成像.CT与MRI杂志,2003,10(1):56-60.
[2]Fox KAA,Poole-vilson P,Clayton TC,et al.Five-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome.the British heart Foundation RITA-3randomised trial.Lancet,2005,366(9489):914-920
[3]Constantine G,Shan K,Flamm SD,et al.Role of MRI in clinical cardiology.Lancet 2004;363(9427):2162-22171
[4]Jahnke C,Paetsch I,Schnackenburg B,et al.Coronary MR angiography with steady-state free precession:individually adapted breath-hold technique versus free-breathing technique.Radiology2004;232(3):669-676
[5]Beer M,Machann W,Sandstede J,et al.Energetic difference between viable and non-viable myocardium in patients with recent myocardial infaction are not an effect of differences in wall thinning-a mutivoxel(31)P-MR-spectroscopy and MRI study.Eur Radiol.2007;17(5):1275-1283
[6]De Filippo M,Julsrud P,Araoz P,et al.MRI evaluation of myocardial viability.Radiol Med (Torino).2006;111(8):1035-1053
[7]Weidensteiner C,Lanz T,Horn M,et al.Three-dimensional in the isolated infarcted rat heart.JMagn Reson.2000;143(1):17-23.
[8]Weidensteiner C,Horn M,Fekete E,et al.Imaging of intracellular sodium with shift reagent aided(23)Na CSI in isolated rat hearts.Magn Reson Med.2002 Jul;48(1):89-96.
[9]Horn M,Weidensteiner C,Scheffer H,et al.Use of 23Na MRS to discriminate viable from non viable tissue:experimental studies.MAGMA.2000;11(1-2):42-3.
[10]Horn M,Weidensteiner C,Scheffer H,et al.Detection of myocardial viability based on measurement of sodium content:A(23)Na-NMR study.Magn Reson Med.2001May;45(5):756-64.
[11]McCommis KS,Goldstein TA,Abendschein DR,et al.Quantification of regional myocardial oxygenation by magnetic resonance imaging:validation with positron emission tomography.Circ Cardiovasc Imaging.2010;3(1):41-46.
[12]Weinsaft JW,Klem I,Judd RM.MRI for the assessment of myocardial viability.Magn Reson Imaging Clin N Am.2007;15(4):505-25.
[13] Kim RJ, Fieno DS, Parrish TB,et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation,1999;100(19):1992-2002
[14] Shan K, Constantine G, Sivananthan M,et al.Role of cardiac magnetic resonance imaging in the assessment of myocardial viability circulation 2004;109(11)1:1328-1334
[15] Moran GR, Thornhill RE, Sykes J,et al. Myocardial viability imaging using Gd-DTPA: physiological modeling of infracted myocardium, and impact on injection strategy and imaging time. Magn Reson Med. 2002 ;48(5):791-800.
[16] Beer M, Machann W, Sandstede J, et al. Energetic difference between viable and non-viable myocardium in patients with recent myocardial infaction are not an effect of differences in wall thinning-a mutivoxel (31)P-MR-spectroscopy and MRI study. Eur Radiol. 2007;17(5):1275-1283
[17] Weidensteiner C, Lanz T, Horn M, et al. Three-dimensional in the isolated infarcted rat heart. J Magn Reson. 2000 ;143(1):17-23.
[18] Weidensteiner C, Horn M, Fekete E,et al. Imaging of intracellular sodium with shift reagent aided (23)Na CSI in isolated rat hearts. Magn Reson Med. 2002 ;48(1):89-96.
[19] Horn M, Weidensteiner C, Scheffer H, et al. Detection of myocardial viability based on measurement of sodium content: A (23)Na-NMR study. Magn Reson Med. 2001 ;45(5):756-64.
[20] McCommis KS, Goldstein TA, Abendschein DR, et al. Quantification of regional myocardial oxygenation by magnetic resonance imaging: validation with positron emission tomography. Circ Cardiovasc Imaging. 2010 ;3(1):41-46.
[21] Kwong RY, Chan AK, Brown K, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circuration 2006; 113 (23) :2733-2743
[22] Rehwald WG,Fieno DS, Chen EL, et al.Myocardial magnetic resonance imaging contrast agent concentration after revisible and irrevible ischemic injury.Circuration,2002;105 (2) :224-229
[23] Higuchi T, Nekolla SG, Jankaukas A,et al. Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI. J Nucl Med. 2007 ;48(2):288-94
[24] Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003 ;361(9355):374-379.
[25] Klein C,Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast enhanced magnetic resonance imagingxomparison with positron emission tomography. Circulation,2002,105(2): 162-167
[26] Wang L, Zhu HY, Tian JM,et al.Magnetic resonance imaging in determination of myocardial ischemia and viabilityxomparison with positron emission tomography and single-photon emission computed tomography in a porcine model. Acta Radiol. 2007 Jun;48(5):500-507
[27] Kanderian AS, Renapurkar R, Flamm SD. Myocardial viability and revascularization. Heart fail Clin. 2009 ;5(3):333-48.
[28] Jerosch-Herold M, Muehling O, Wilke N. MRI of myocardial perfusion. Semin Ultrasound CT MR.2006;27(1):2-10.
[29] Sakuma H. Magnetic resonance imaging for ischemic heart diasease.J Magn Reson Imaging.2007 26(1):3-13
[30] Thornhill RE, Prato FS, Wisenberg G. The assessment of myocardial viability: a review of current diagnostic imaging approaches. J Cardiovasc Magn Reson. 2002;4(3):381-410.
[31] Gerber BL,Garot J, Bluemke DA, et al. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction.Circulation.2002;106(9):1083-1089
[32] Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation,2004,109( 18):2172-2174
[33] Ogawa M, Doi K, Fukumoto A,et al. Reverse-remodeling after coronary artery bypass grafting in ischemic cardiomyopathy: assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons.Interact Cardiovasc Thorac Surg. 2007 ;6(5):673-675
[34] Ogawa M, Doi K, Yamada Y, et al. Surgical ventricular restoration based on evaluation of myocardial viability withdelayed-enhanced magnetic resonance imaging.Gen Thorac Cardiovasc Surg. 2007 ;55(4):149-57
[35] Suh WM, Fowler SJ, Wallis JB, et al. Utility of cardiac MRI in guiding revascularization therapy in unprotected left main stenosis: a case report.Cardiovasc Revasc Med. 2007 Jul-Sep;8(3):209-12
[36] Selvanayagam JB,Kardos A, Francis JM, et al.Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularison. Circulation 2004.110(12):1535-1541
[37] Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.N Engl J Med.2000,343(20):1445-1453
[38] Kitagawa K,Sakuma H, HiranoT, et al. Acute myocardial infarction:myocardial viability assessment in patients early therafter comparison of contrast-enhanced MR imaging with resting(201)TI SPECT.single . photon emission computed tomography. Radiology,2003,226(1):138-144
[39] Kuhl HP, Beek AM, van der Weerdt AP, et al. Myocarial viability in chronic ischemic heart diasease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol,2003,41(8):1341-1348
[40] Cheong BY, Muthupillai R, Wilson JM, et al. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation. 2009 Nov 24;120(21):2069-76. Epub 2009 Nov 9.
[41] Yan AT, Shayne AJ, Brown KA, et al. Characterization of peri-infarct zone by contrast enhanced cardiac magnetic resonance imaging is a pownful predictor of post-myocardial infarction mortality. Circulation 2006;114(1):32-39
[42] Duffy KJ, Ferrari VA.Prognosis following acute myocardial infarction: insights from cardiovascularmagnetic resonance. Curr Cardiol Rep. 2007 ;9(1):57-62
[43] Beeres SL, Bengel FM, Bartunek J,et-al. Role of imaging in cardiac stem cell therapy. J Am Coll Cardiol.2007 Mar 20;49(11):1137-48. 2007;49(11):1137-1148
[44] Dick AJ, Guttman MA, Raman VK, et-al.Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in Swine.Circulation. 2003 ;108(23):2899-2904
[45] Fieno DS,Kim RJ,Chen EL, et al. Contrast-enhanced magnetic resonce imaging of myocardium at risk:distinction between resersible and irreversible injury througuout infact healing. J Am Cardiol,2000,36:1985-1991
[46] Oshinski JN, Yang Z, Jones JR., et al. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001; 104 (23) :2838-2842
[47] Saeed M, Lund G, Wendland MF, et al. Magnetic resonance characterization of the peri-infaction zone of reperfused myocardioal infaction with necrosis-specific and extracellular nonspecific contast media. Circulation,2001,103(6):1083-1089
[48] Nguyen TD, Spincemaille P, Weinsaft JW, et al. A fast navigator-gated 3D sequence for delayed enhancement MRI of the myocardium: comparison with breathhold 2D imaging. J Magn Reson Imaging. 2008 Apr;27(4):802-8.